Mylan Institutional, Inc. (d.b.a. UDL Laboratories) recalls Fexofenadine Hydrochloride Tablets, USP 60 mg, Allergy, Non-Drowsy, Antihistamine, 100 tablets (10 X 10) per UD Cartons…
- Recall date
- March 26, 2015
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- D-1083-2015
- FDA classification
- Class III
- Brand / firm
- Mylan Institutional, Inc. (d.b.a. UDL Laboratories)
- Sold / distributed
- Nationwide
Why it was recalled
Failed Impurities/Degradation Specifications: the manufacturer, recalled product due to slightly above specification results for a Related Compound during routine stability testing
Class III means the product violates regulations but is not likely to cause harm.
What was recalled
Fexofenadine Hydrochloride Tablets, USP 60 mg, Allergy, Non-Drowsy, Antihistamine, 100 tablets (10 X 10) per UD Cartons, Manufactured by: Mylan Pharmaceuticals Inc., Morgantown, WV 26505, USA, NDC 51079-547-20
Get recall alerts
Free email alert whenever Mylan Institutional, Inc. (d.b.a. UDL Laboratories) has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Mylan Institutional, Inc. (d.b.a. UDL Laboratories)